耐多药结核病——预防和控制的关键步骤

被引：11

作者：

Eva Nathanson

Paul Nunn

Mukund Uplekar

Katherine Floyd

Ernesto Jaramillo

Knut Lnnroth

Diana Weil

Mario Raviglione

王细文

机构：

[1] FromtheStopTBDepartment,WorldHealthOrganization

来源：

中华肺部疾病杂志(电子版) | 2010年 / 3卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R52 [结核病];

学科分类号：

100201 [内科学];

摘要：

<正>耐多药结核病(multidrug-resistant tuberculosis,MDR-TB)被定义为,由至少对异烟肼(isoniazid)和利福平(rifampicirn)治疗耐药的结核分枝杆菌(Mycobacterium tuberculosis)引起的疾病。广泛耐药结核病(extensively drug-resistant,tuberculosis,XDR-TB)是指导疾病的多重耐药菌株还对使用任

引用

页码：443 / 450

页数：8

共 10 条

[1]

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis [J].

Orenstein, Evan W. ;

Basu, Sonjay ;

Shah, N. Sarita ;

Andrews, Jason R. ;

Friedland, Gerald H. ;

Moll, Anthony P. ;

Gandhi, Neel R. ;

Galvani, Alison P. .

LANCET INFECTIOUS DISEASES, 2009, 9 (03) :153-161

[2]

Ministerial meeting agrees plan for tuberculosis control [J].

Cheng, Margaret Harris .

LANCET, 2009, 373 (9672) :1328-1328

[3]

Unsexy tuberculosis [J].

Reichman, Lee B. .

LANCET, 2009, 373 (9657) :28-28

[4]

Over the Counter Availability of Antituberculosis Drugs in Tbilisi; Georgia in the Setting of a High Prevalence of MDR-TB.[J].Ketevan Kobaidze;Archil Salakaia;Henry M. Blumberg;Jonathan Mayer.Interdisciplinary Perspectives on Infectious Diseases.2009,

[5]

Substandard medicines in resource-poor settings:: a problem that can no longer be ignored [J].